Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single-dose ASP5354 IV study in healthy Japanese males
jRCT2071210026Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2021
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial comparing ASP5354 with Placebo (2 arms). Primary endpoints: Adverse events, Laboratory values and 2 more. Started Jun 2021; status: completed.
02
Drugs
pudexacianinium chloride
Beyond the preview
Go deeper on jRCT2071210026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210026.